361 related articles for article (PubMed ID: 30423020)
1. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
Zhu W; Reuter S; Field LJ
Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
[TBL] [Abstract][Full Text] [Related]
2. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
Zhu W; Zhang W; Shou W; Field LJ
Cardiovasc Res; 2014 Jul; 103(1):81-9. PubMed ID: 24812279
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.
Toischer K; Zhu W; Hünlich M; Mohamed BA; Khadjeh S; Reuter SP; Schäfer K; Ramanujam D; Engelhardt S; Field LJ; Hasenfuss G
J Clin Invest; 2017 Dec; 127(12):4285-4296. PubMed ID: 29083322
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
Matsumura N; Zordoky BN; Robertson IM; Hamza SM; Parajuli N; Soltys CM; Beker DL; Grant MK; Razzoli M; Bartolomucci A; Dyck JRB
Cardiovasc Res; 2018 Aug; 114(10):1350-1359. PubMed ID: 29566148
[TBL] [Abstract][Full Text] [Related]
6. Cell Cycle-Mediated Cardiac Regeneration in the Mouse Heart.
Eghbali A; Dukes A; Toischer K; Hasenfuss G; Field LJ
Curr Cardiol Rep; 2019 Sep; 21(10):131. PubMed ID: 31529165
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
9. [Heat shock protein 27 attenuated doxorubicin-induced myocardial damage by reducing cardiomyocyte apoptosis, mitochondria damage and protein carbonylation].
Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1021-6. PubMed ID: 19102918
[TBL] [Abstract][Full Text] [Related]
10. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
11. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z
Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505
[TBL] [Abstract][Full Text] [Related]
12. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
13. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.
Zhu W; Soonpaa MH; Chen H; Shen W; Payne RM; Liechty EA; Caldwell RL; Shou W; Field LJ
Circulation; 2009 Jan; 119(1):99-106. PubMed ID: 19103993
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.
Hassink RJ; Pasumarthi KB; Nakajima H; Rubart M; Soonpaa MH; de la Rivière AB; Doevendans PA; Field LJ
Cardiovasc Res; 2008 Apr; 78(1):18-25. PubMed ID: 18079102
[TBL] [Abstract][Full Text] [Related]
18. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).
Cheng Z; DiMichele LA; Rojas M; Vaziri C; Mack CP; Taylor JM
J Mol Cell Cardiol; 2014 Feb; 67():1-11. PubMed ID: 24342076
[TBL] [Abstract][Full Text] [Related]
20. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.
Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y
PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
